NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Climate change iStock image
It’s no secret that agriculture is highly dependent on climate, and the effects of global warming on crops are a complex problem. Those recognitions were jumping-off points for discussions from executives of two of North Carolina’s leading global agricultural biotechnology companies during NCBiotech's Ag Tech Professional Forum.

With uncertain weather forecast, the NCBiotech RTP office is opening at noon on Wednesday February 20.

Many of us will be checking in from home. Please stay safe out there.

LabCorp logo
Burlington-based LabCorp is offering a new assay to help doctors monitor drug responses in patients taking Certolizumab, a biologic therapy for certain inflammatory diseases such as rheumatoid arthritis and Crohn’s disease.
AveXis logo
North Carolina’s global gene therapy leadership was boosted today with the announcement that AveXis, Inc., is doubling its planned workforce and investing $60 million more in its new Durham County manufacturing facility.
Glenmark logo
Glenmark Pharmaceuticals, the largest pharmaceutical manufacturer in the Greater Charlotte region, is bringing a big “Help Wanted” message to the North Carolina Biotechnology Center’s monthly Jobs Network event, in search of production employees to help meet its fast-growing demand.
Syneos logo
Syneos Health is joining the worldwide annual observance of Rare Disease Day, Thursday, February 28, by hosting a free public in-depth Rare Disease Day Symposium, from 11:30 a.m. to 3 p.m., at its new global headquarters in Morrisville.
Durham-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has launched a new observational study of several inflammatory skin conditions, initially focusing on eczema.
AAAS logo
Two Triangle scientists, including NCBiotech staff member Tracey du Laney, Ph.D., and Duke University researcher Kafui Dzirasa, Ph.D., M.D., are among 10 honored today with prestigious fellowships from the American Association for the Advancement of Science.
Sapere logo
Sapere Bio is a 6-year-old Research Triangle-based startup using biomarkers to predict biological age so people can stay healthy longer.
BPD logo
New entrants to the biomanufacturing industry recently described for an enthusiastic audience at an NCBiotech event that they're experiencing incredible opportunity, thanks to North Carolina's workforce training system and excellent pool of grateful employers.
IQVIA Biotech logo
IQVIA, established two years ago following the 2016 merger of Research Triangle-based Quintiles and IMS Health, has announced the launch of IQVIA Biotech. This new unit will design clinical and commercial solutions for small biotechnology and biopharmaceutical companies.
According to a report published by Xconomy, startups often look to San Francisco and Silicon Valley for the venture capital they need. But they don’t have to locate there to attract funding. And they might be wiser to consider a lower-cost region like the Raleigh-Durham area instead.
Actus logo
Actus Therapeutics of Chapel Hill has dosed the first patient in a phase 1/2 clinical study of its gene therapy in patients with Pompe disease, a rare genetic disorder that often leads to premature death in children and adults.
LabCorp logo
Burlington-based healthcare diagnostics company LabCorp has donated $1 million to Alamance Community College (ACC) to support the school’s growing biotechnology and life science curricula.
The North Carolina Biotechnology Center awarded 17 grants and loans totaling nearly $1.4 million to universities, bioscience companies and other organizations in the second quarter of its current fiscal year.